Skip to main content

Table 6 Numbers assessed at each time period in each treatment group

From: The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI

 

Control

Patient

    
  

Any

High Risk

Low Risk

   

XRT

HDM

HDM

IT MTX

Any test

311

555

77

79

202

197

5 month test

161

305

47

42

104

112

3 year test

173

369

51

45

139

134

5 year test

132

289

34

35

116

104

5 month only

92

133

23

28

35

47

3 year only

57

94

15

16

34

29

5 year only

37

40

3

6

21

10

5 month and 3 year only

30

39

5

0

17

17

5 month and 5 year only

9

13

0

0

7

6

3 year and 5 year only

56

116

12

15

43

46

All 3 tests

30

120

19

14

45

42